NCT05827679

Brief Summary

Every year in France, 60,000 children are born prematurely (before 37 weeks of amenorrhea), and present an immaturity of their various systems, in particular the digestive system. This can result in feeding intolerance, which is expressed by abdominal distension, regurgitation or vomiting, irregular transit and abdominal discomfort. This feeding intolerance influences the length of hospitalization and can lead to necrotising enterocolitis, a major complication. In the Neonatal Intensive Care Units of Clermont-Ferrand hospital center, abdominal massages have been performed by physiotherapists for several years in order to improve the condition of the digestive system. However, the indication for abdominal massage is very dependent on the caregivers in charge of the newborn and the evaluation of the abdominal condition remains subjective with a great variability between examiners. Thus, some newborns will receive massage multiple times a day while others will not. Developmental care is essential for these premature infants, especially to avoid over-stimulation. It is important not to add care, such as massage, if it is not needed. It is therefore essential to properly assess the digestive status of premature babies in order to determine whether they have feeding intolerance and whether they require treatment with abdominal massage. To date, the investigators have not found measurable criteria or existing scales that can describe the digestive status of newborns. The main objective of the study is therefore to create and validate a clinical assessment scale for the abdominal status of preterm infants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2023

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

March 23, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 25, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

September 15, 2023

Status Verified

April 1, 2023

Enrollment Period

6 months

First QC Date

March 23, 2023

Last Update Submit

September 14, 2023

Conditions

Keywords

physiotherapyabdominal massage

Outcome Measures

Primary Outcomes (1)

  • Clinical Abdominal assessment scale for Preterm infant (ECAP scale)

    score between 0 and 20

    up to 18 months

Secondary Outcomes (3)

  • Indication for abdominal massage on ECAP scale

    up to 18 months

  • ECAP scale validity

    up to 18 months

  • impact of massage on ECAP scale

    up to 18 months

Eligibility Criteria

Age3 Days - 60 Days
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Newborns born before 37 weeks of amenorrhea, hospitalized in the neonatal intensive care units

You may qualify if:

  • newborns, born prematurely (before 37 weeks of amenorrhea)
  • at least 3 days of life
  • hospitalized in the neonatal intensive care units
  • whose holders of parental authority are able to give free and informed consent to participate in this study

You may not qualify if:

  • Newborns with congenital pathology such as malformation, genetic or chromosomal abnormality.
  • Newborns whose holders of parental authority are protected by law (under guardianship) or under the age of 18.
  • Rejection of participation by parents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU clermont-ferrand

Clermont-Ferrand, 63000, France

Location

MeSH Terms

Conditions

Digestive System Diseases

Study Officials

  • Marie COLNÉ

    mcolne@chu-clermontferrand.fr

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2023

First Posted

April 25, 2023

Study Start

March 15, 2023

Primary Completion

September 1, 2023

Study Completion

September 1, 2023

Last Updated

September 15, 2023

Record last verified: 2023-04

Locations